Solutions
About Us
Insights
Careers

Epidemiology and treatment patterns of essential tremor: a retrospective cohort analysis in Germany. Becktepe JS, O’Neill K, Müller S, Wilke T, Zhuleku E, Appiah K, Dzimitrowicz N, Marshall J, Sabater J, Barbato LM, Saifee TA. Front Neurol. 2025

How much can we save by applying artificial intelligence in evidence synthesis? Results from a pragmatic review to quantify workload efficiencies and cost savings. Abogunrin S, Muir JM, Zerbini C, Sarri G. Front Pharmacol. 2025

Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study. Whalen J, Chandra A, Kracker S, Ehl S, Seidel MG, Gulas I, Dron L, Velummailum R, Nagamuthu C, Liu S, Tutein Nolthenius J, Maccari ME. Clin Exp Immunol. 2025

Overall Survival and Treatment Patterns Among Patients With Warm Autoimmune Hemolytic Anemia in Sweden: A Nationwide Population-based Study. Cherif H, Cai Q, Crivera C, Leon A, Rahman I, Leval A, Noel W, Kjellander C. Eur J Haematol. 2025

Survival trends using DPd vs. other triplets in early RRMM patients: a population-adjusted indirect treatment comparison. Anwer F, Lan T, Dolph M, Moradian H, Slaff S, Shih YH, Tang D. Future Oncol. 2025

Recurrence of Cardiovascular Events After an Acute Myocardial Infarction in Patients with Multivessel Disease and Associated Healthcare Costs: A German Claims Data Analysis. Starry A, Picker N, Galduf J, Maywald U, Dittmar A, Spitzer SG. Pharmacoeconomics. 2025

Split-Dose Cisplatin Use, Eligibility Criteria, and Drivers for Treatment Choice in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: Results of a Large International Physician Survey. O’Dwyer R, Junker S, Szulkin R, Kienzle S, Kearney M, Sridhar SS. Cancers (Basel). 2025

Assessing the economic impact and healthcare resource utilization of inpatient pneumococcal disease among adults: a French national claims database study. Bailey MD, Farge G, Breau Brunel M, Mohanty S, Roy G, de Pouvourville G, de Wazieres B, Janssen C, Tauty S, Bugnard F, Goguillot M, Bénard S, Johnson KD. J Med Econ. 2025

Real-world experience with filgotinib for rheumatoid arthritis in Germany : A retrospective chart review. Schultz O, Fiehn C, Kneitz C, Picker N, Kromer D, Zignani M, De Leonardis F, Orzechowski HD, Gurrath M, Krüger K. Z Rheumatol. 2025

Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Disanto G, Schaedelin S, Oechtering J, Lorscheider J, Galbusera R, Finkener S, Achtnichts L, Lalive P, Müller S, Pot C, Hoepner R, Salmen A, Zecca C, Hemkens LG, D’Souza M, Fischer-Barnicol B, Du Pasquier R, Roth P, Yaldizli Ö, Einsiedler M, Derfuss T, Kappos L, Gobbi C, Granziera C, Uginet M, Maceski AM, O’Neill K, Leppert D, Benkert P, Kuhle J; Swiss MS Cohort Study. Mult Scler J Exp Transl Clin. 2025